The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
The Current State of Knowledge on Age, Sex, and Their Interactions on Clinical Pharmacology
Abstract
Pharmacokinetic and pharmacodynamic changes occur with increasing age. Sex differences in pharmacokinetics and pharmacodynamics exist and persist at older age. The issue for the clinician is how to best treat the older patient with currently available knowledge. This communication highlights age- and sex-related differences in pharmacokinetics that should influence clinical practice and prescribing guidelines to optimize clinical responses. The most compelling data for sex-specific medication dosing guidelines for older patients are related to volume of distribution differences, or size differences, between the sexes and to differences in glomerular filtration rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952
Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., & Mitchell, A. A. (2002) · JAMA · doi:10.1001/jama.287.3.337 · Cited by 1,845
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
Gurwitz, J. H., Field, T. S., Harrold, L. R., Rothschild, J., Debellis, K., Seger, A. C., Cadoret, C., Fish, L. S., Garber, L., Kelleher, M., et al. (2003) · JAMA · doi:10.1001/jama.289.9.1107 · Cited by 1,676
Effect of VKORC1 Haplotypes on Transcriptional Regulation and Warfarin Dose
Rieder, M. J., Reiner, A. P., Gage, B. F., Nickerson, D. A., Eby, C. S., McLeod, H. L., Blough, D. K., Thummel, K. E., Veenstra, D. L., & Rettie, A. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044503 · Cited by 1,399
Adverse Drug Events in Ambulatory Care
Gandhi, T. K., Weingart, S. N., Borus, J., Seger, A. C., Peterson, J., Burdick, E., Seger, D. L., Shu, K., Federico, F., Leape, L. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmsa020703 · Cited by 1,345
Frezza, M., di Padova, C., Pozzato, G., Terpin, M., Baraona, E., & Lieber, C. S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220205 · Cited by 1,328
Drug Metabolism and Variability among Patients in Drug Response
Wilkinson, G. R. (2005) · New England Journal of Medicine · doi:10.1056/nejmra032424 · Cited by 1,185
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
Torp-Pedersen, C., Møller, M., Bloch-Thomsen, P. E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012
Identification of functionally variant MDR1 alleles among European Americans and African Americans
Kim, R. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117412 · Cited by 1,009
Aging Biology and Geriatric Clinical Pharmacology
McLean, A. J., & Le Couteur, D. G. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.4 · Cited by 771
Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials
Heiat, A., Gross, C. P., & Krumholz, H. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1682 · Cited by 723
Alexander, K. P. (2005) · JAMA · doi:10.1001/jama.294.24.3108 · Cited by 677
Exploring the Biological Contributions to Human Health: Does Sex Matter?
(2001) · National Academies Press eBooks · doi:10.17226/10028 · Cited by 653
Cerivastatin and Reports of Fatal Rhabdomyolysis
Staffa, J. A., Chang, J., & Green, L. (2002) · New England Journal of Medicine · doi:10.1056/nejm200202143460721 · Cited by 626
OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine
Cvetkovic, M., Leake, B., Fromm, M. F., Wilkinson, G. R., & Kim, R. B. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15235-x · Cited by 597
Olanzapine: Pharmacokinetic and Pharmacodynamic Profile
Callaghan, J. T., Bergstrom, R. F., Ptak, L. R., & Beasley, C. M. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937030-00001 · Cited by 544
Sex Differences in Pharmacokinetics and Pharmacodynamics
Gandhi, M., Aweeka, F., Greenblatt, R. M., & Blaschke, T. F. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121453 · Cited by 542
Sex Is A Major Determinant of Cyp3a4 Expression in Human Liver
Wolbold, R., Klein, K., Burk, O., Nüssler, A. K., Neuhaus, P., Eichelbaum, M., Schwab, M., & Zanger, U. M. (2003) · Hepatology · doi:10.1002/hep.1840380424 · Cited by 529
The Influence of Sex on Pharmacokinetics
Schwartz, J. B. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342020-00001 · Cited by 467
Self-citationSingh, S., Zoble, R. G., Yellen, L., Brodsky, M. A., Feld, G. K., Berk, M., & Billing, C. B. (2000) · Circulation · doi:10.1161/01.cir.102.19.2385 · Cited by 433
Sotaniemi, E. A., Arranto, A. J., Pelkonen, O., & Pasanen, M. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90166-1 · Cited by 415
Gorski, J. C., Jones, D. R., Haehner-Daniels, B. D., Hamman, M. A., O'Mara, E. M., & Hall, S. D. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90146-1 · Cited by 411
Risk Factors for Adverse Drug Events Among Nursing Home Residents
Field, T. S., Gurwitz, J. H., Avorn, J., McCormick, D., Jain, S., Eckler, M., Benser, M., & Bates, D. W. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1629 · Cited by 411
The incidence of adverse drug events in two large academic long-term care facilities
Gurwitz, J. H., Field, T. S., Judge, J., Rochon, P., Harrold, L. R., Cadoret, C., Lee, M., White, K., LaPrino, J., Erramuspe-Mainard, J., et al. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.09.018 · Cited by 404
PARKINSON, A. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.01.010 · Cited by 386
Patient Risk Factors for Adverse Drug Events in Hospitalized Patients
Bates, D. W. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.21.2553 · Cited by 330
Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2* activities
Relling, M. V., Lin, J.-S., Ayers, G. D., & Evans, W. E. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.203 · Cited by 314
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
Cotreau, M. M., von Moltke, L. L., & Greenblatt, D. J. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00002 · Cited by 292
High Blood Alcohol Levels in Women
(1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230113 · Cited by 289
Prediction equations to estimate glomerular filtration rate: an update
Manjunath, G., Sarnak, M. J., & Levey, A. S. (2001) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200111000-00009 · Cited by 277
Schuetz, E. G., Furuya, K. N., & Schuetz, J. D. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12089-2 · Cited by 265
Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities
Kalow, W., & Tang, B.-K. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.176 · Cited by 261
Alexander, K. P., Chen, A. Y., Newby, L. K., Schwartz, J. B., Redberg, R. F., Hochman, J. S., Roe, M. T., Gibler, W. B., Ohman, E. M., & Peterson, E. D. (2006) · Circulation · doi:10.1161/circulationaha.106.620815 · Cited by 260
Self-citationJusko, W. J., Gardner, M. J., Mangione, A., Schentag, J. J., Koup, J. R., & Vance, J. W. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600681106 · Cited by 251
Liver Function and Phase I Drug Metabolism in the Elderly: A Paradox
Schmucker, D. L. (2001) · Drugs & Aging · doi:10.2165/00002512-200118110-00005 · Cited by 249
Sex-Dependent Metabolism of Xenobiotics
Mugford, C. A., & Kedderis, G. L. (1998) · Drug Metabolism Reviews · doi:10.3109/03602539808996322 · Cited by 244
Gender differences in pharmacokinetics and pharmacodynamics.
Beierle, I., Meibohm, B., & Derendorf, H. (1999) · PubMed · Cited by 230
Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin
Kamali, F., Khan, T. I., King, B. P., Frearson, R., Kesteven, P., Wood, P., Daly, A. K., & Wynne, H. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.10.001 · Cited by 218
Principles of Gender-Specific Medicine
(2010) · Elsevier eBooks · doi:10.1016/c2009-0-03574-0 · Cited by 212
Effects of age and gender on in vitro properties of human liver microsomal monooxygenases
Schmucker, D. L., Woodhouse, K. W., Wang, R. K., Wynne, H., James, O. F., McManus, M., & Kremers, P. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.164 · Cited by 207
Bock, K. W., Schrenk, D., Forster, A., Griese, E.-U., M??rike, K., Brockmeier, D., & Eichelbaum, M. (1994) · Pharmacogenetics · doi:10.1097/00008571-199408000-00005 · Cited by 199
Lansky, A. J., Pietras, C., Costa, R. A., Tsuchiya, Y., Brodie, B. R., Cox, D. A., Aymong, E. D., Stuckey, T. D., Garcia, E., Tcheng, J. E., et al. (2005) · Circulation · doi:10.1161/01.cir.0000160362.55803.40 · Cited by 191
Human gastric alcohol dehydrogenase activity: effect of age, sex, and alcoholism.
Seitz, H. K., Egerer, G., Simanowski, U. A., Waldherr, R., Eckey, R., Agarwal, D. P., Goedde, H. W., & von Wartburg, J. P. (1993) · Gut · doi:10.1136/gut.34.10.1433 · Cited by 191
Bioequivalence revisited: Influence of age and sex on CYP enzymes
Bebia, Z., Buch, S. C., WILSON, J., Frye, R. F., Romkes-Sparks, M., Cecchetti, A. A., Chaves‐Gnecco, D., & BRANCH, R. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.08.021 · Cited by 179
The Biology of Human Sex Differences
Federman, D. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052529 · Cited by 170
Cummins, C. L., Wu, C., & Benet, L. Z. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.128388 · Cited by 166
Tamminga, W. J., Wemer, J., Oosterhuis, B., Wieling, J., Wilffert, B., de Leij, L. F. M. H., de Zeeuw, R. A., & Jonkman, J. H. G. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050615 · Cited by 166
Lane, H.-Y., Chang, Y.-C., Chang, W.-H., Lin, S.-K., Tseng, Y.-T., & Jann, M. W. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0108 · Cited by 158
de Werf, F. V. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2686 · Cited by 147
Roy, S. D., & Flynn, G. L. (1990) · Pharmaceutical Research · doi:10.1023/a:1015912932416 · Cited by 146
Gender Differences in the Membrane Transport of Endogenous and Exogenous Compounds
Morris, M. E., Lee, H., & Predko, L. M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.1 · Cited by 140
Kinirons, M. T., O’Shea, D., Kim, R. B., Groopman, J. D., Thummel, K. E., Wood, A. J. J., & Wilkinson, G. R. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70029-9 · Cited by 134
Phenotypic polymorphism and gender‐related differences of CYP1A2 activity in a Chinese population
Ou‐Yang, D., Huang, S., Wang, W., Xie, H., Xu, Z., Shu, Y., & Zhou, H. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00128.x · Cited by 133
GRUBB, A. O., Björk, J., Lindström, V., Sterner, G., Bondesson, P., & Nyman, U. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510510013596 · Cited by 131
Ammon, E., Schäfer, C., Hofmann, U., & Klotz, U. E. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90178-2 · Cited by 125
Rehman, H. U., & Masson, E. A. (2001) · Age and Ageing · doi:10.1093/ageing/30.4.279 · Cited by 120
Wasén, E., Isoaho, R. E., Mattila, K. S., Vahlberg, T. J., Kivelä, S., & Irjala, K. M. A. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01340.x · Cited by 116
Gender‐Specific Effects on Verapamil Pharmacokinetics and Pharmacodynamics in Humans
KRECICSHEPARD, M., Barnas, C., SLIMKO, J., Jones, M. P., & Schwartz, J. B. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022008883 · Cited by 116
Self-citationVerapamil disposition kinetics in chronic atrial fibrillation
Kates, R. E., Keefe, D. L., Schwartz, J. B., Harapat, S. R., Kirsten, E. B., & Harrison, D. C. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.125 · Cited by 114
Self-citationLabbé, L., Sirois, C., Pilote, S., Arseneault, M., Robitaille, N., Turgeon, J., & Hamelin, B. A. (2000) · Pharmacogenetics · doi:10.1097/00008571-200007000-00006 · Cited by 112
Race and sex influence clearance of nifedipine: Results of a population study
KRECICSHEPARD, M. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.108678 · Cited by 104
haplotype structure in European American warfarin patients and association with clinical outcomes
Veenstra, D., Blough, D. K., Higashi, M. K., Farin, F. M., Srinouanprachan, S., Rieder, M. J., & Rettie, A. E. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.01.019 · Cited by 102
Altered Pharmacokinetics in the Elderly
Yuen, G. J. (1990) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30615-3 · Cited by 98
Altered Pharmacodynamics in the Elderly
John, F., & Davis, C. (1990) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30616-5 · Cited by 87
Kashuba, A. D. M., Bertino, J., KEARNS, G., Leeder, J. S., James, A. W., Gotschall, R. R., & Nafziger, A. N. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90105-9 · Cited by 86
An Evaluation of Antiepileptic Drug Therapy In Nursing Facilities
Schacbter, S. C., Cramer, G. W., Thompson, G. D., Chaponis, R. J., Mendelson, M. A., & Lawborne, L. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb06654.x · Cited by 78
石澤, 幸., Yasui‐Furukori, N., Takahata, T., Sasaki, M., & Tateishi, T. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544110-00005 · Cited by 71
Dorne, J. L. C. M., Walton, K., Slob, W., & RENWICK, A. G. (2002) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00117-5 · Cited by 70
Sex differences in CYP3A activity using intravenous and oral midazolam
CHEN, M., MA, L., Drusano, G. L., BERTINOJR, J., & Nafziger, A. N. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.08.014 · Cited by 68
Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis
Bruno, R., Vivier, N., Montay, G., Liboux, A. É., Powe, L. K., Delumeau, J.-C., & Rhodes, G. R. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90047-3 · Cited by 63
The biology and physiology of aging.
Abrass, I. B. (1990) · PubMed Central · Cited by 61
Cystatin C reference values and aging
Ognibene, A., Mannucci, E., Caldini, A. L., Terreni, A., Brogi, M., Bardini, G., Sposato, I., Mosconi, V., Salvadori, B., Rotella, C. M., et al. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.03.017 · Cited by 59
Population analyses of sustained‐release verapamil in patients: Effects of sex, race, and smoking
Kang, D., Verotta, D., KRECICSHEPARD, M., Modi, N. B., Gupta, S., & Schwartz, J. B. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.21 · Cited by 54
Self-citationNeoral use in the cardiac transplant recipient
Valantine, H. A. (2000) · Transplantation Proceedings · doi:10.1016/s0041-1345(00)00862-9 · Cited by 48
Bartoli, A., Xiaodong, S., Gatti, G., Cipolla, G., Marchiselli, R., & Perucca, E. (1996) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199610000-00011 · Cited by 47
KRECICSHEPARD, M., Barnas, C., SLIMKO, J., et al. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70052-4 · Cited by 45
Differential Pharmacokinetics of Theophylline in Elderly Patients
Ohnishi, A., Kato, M., Kojima, J., Ushiama, H., Yoneko, M., & Kawai, H. (2003) · Drugs & Aging · doi:10.2165/00002512-200320010-00005 · Cited by 44
Erythromycin breath test results in elderly, very elderly, and frail elderly persons
Schwartz, J. B. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.01.006 · Cited by 41
Self-citationBenet, L. Z. (2005) · Molecular Interventions · doi:10.1124/mi.5.2.5 · Cited by 40
Differential Kinetics of Phenytoin in Elderly Patients
Bachmann, K. A., & Belloto, R. J. (1999) · Drugs & Aging · doi:10.2165/00002512-199915030-00006 · Cited by 36
Reis, M., Procházka, J., Sitsen, A. J. M., Ahlner, J., & Bengtsson, F. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000158873.54100.d4 · Cited by 34
Schwartz, J. B. (2003) · Cardiology in Review · doi:10.1097/01.crd.0000078842.86834.93 · Cited by 33
Self-citationEffect of Age on in Vitro Triazolam Biotransformation in Male Human Liver Microsomes
Patki, K. C., Moltke, L. L., Harmatz, J. S., Hesse, L. M., Court, M. H., & Greenblatt, D. J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059311 · Cited by 31
The Age/Gender Interface in Geriatric Pharmacotherapy
Gurwitz, J. H. (2005) · Journal of Women s Health · doi:10.1089/jwh.2005.14.68 · Cited by 25
KANG, D., Verotta, D., & Schwartz, J. B. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.09.007 · Cited by 23
Self-citationO’Connell, M. B., Frye, R. F., Matzke, G. R., Peter, J. V. S., Willhite, L. A., Welch, M. R., Kowal, P. R., & Valleur, J. L. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006292249 · Cited by 23
Application of population pharmacokinetics to the optimization of theophylline therapy
Otero, M. J., Buelga, D. S., Vázquez, M. A., Barrueco, M., & Domínguez‐Gil, A. (1996) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1996.tb00009.x · Cited by 22
Fontana, R. J., deVries, T., Woolf, T. F., Knapp, M. J., Brown, A. S., Kaminsky, L. S., Tang, B., Foster, N. L., Brown, R. R., & Watkins, P. B. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00776.x · Cited by 21
Grines, C. L. (2000) · Circulation · doi:10.1161/01.cir.101.21.e200 · Cited by 15
Effects of age and the CYP2D6∗10 allele on the plasma haloperidol concentration/dose ratio
Ohara, K., Tanabu, S., Ishibashi, K., et al. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00314-7 · Cited by 14
Purnell, B. A., Roberts, L. J., & Smith, O. M. (2005) · Science · doi:10.1126/science.308.5728.1569 · Cited by 11
Aging and the response to inhibition and induction of theophylline metabolism
Vestal, R. E., Cusack, B. J., Crowley, J. J., & Loi, C. (1993) · Experimental Gerontology · doi:10.1016/0531-5565(93)90068-o · Cited by 10
Cited by
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
“In humans the differences are more subtle and their relevance for drug treatment is a matter of continuous concern (Gandhi et al., 2004; Schwartz, 2007; Waxman & Holloway, 2009).”
BackgroundConsensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Pharmacokinetics and drug metabolism in the elderly
Klotz, U. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902722679 · Cited by 826
“…0360-2532 print/ISSN 1097-9883 online © 2009 Informa UK Ltd DOI: 10.1080/03602530902722679 Keywords: Pharmacokinetics; drug metabolism; elderly; kidney function; liver function; cytochrome P450; clearance; frailty http://www.informapharmascience.com/dmr 2004; Schwartz, 2007; Wauthier et al., 2007).”
InfluentialSex differences in pharmacokinetics predict adverse drug reactions in women
Zucker, I., & Prendergast, B. J. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00308-5 · Cited by 777
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
Waxman, D. J., & Holloway, M. G. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056705 · Cited by 815
Metadata
- Authors
- Schwartz, J. B.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2007-05-09
- Volume
- 82
- Issue
- 1
- Pages
- 87-96
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W1965518725
- Cited by
- 256
- References
- 94
- FWCI
- 14.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.